​

Funding Round

Venture Round - Orphazyme

Venture Round - Orphazyme

Investment Firm

Overview

Orphazyme develops innovative new therapies for the treatment of a family of serious genetic disorders called lysosomal storage diseases.

Announced Date

Mar 08, 2017

Funding Type

Series Unknown

Highlights

Location

Europe

Social

Investor Lead

N/A

Participant Investors

6

Investor Name
Participant InvestorKurma Partners
Participant InvestorNovo Holdings
Participant InvestorAescap Venture
Participant InvestorIdinvest Partners
Participant InvestorSunstone Life Science Ventures

Round Details and Background

Orphazyme raised $14762934 on 2017-03-08 in Venture Round

Orphazyme develops innovative new therapies for the treatment of a family of serious genetic disorders called lysosomal storage diseases.

Company Funding History

7

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Mar 08, 2017
Venture Round - Orphazyme
7-14.8M
Jan 09, 2015
Series B - Orphazyme
4-24.0M
Sep 07, 2011
Series A - Orphazyme
3-20.0M
Feb 14, 2011
Seed Round - Orphazyme
2-undefined

Recent Activity

There is no recent news or activity for this profile.